HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Stephan Thurau Selected Research
Stephan Thurau Research Topics
Disease
7
Uveitis
09/2023 - 02/2014
4
Inflammation (Inflammations)
05/2022 - 11/2010
2
Atopic Dermatitis (Atopic Eczema)
05/2019 - 09/2018
2
Conjunctivitis
05/2019 - 09/2018
2
Eye Diseases (Eye Disease)
03/2017 - 02/2017
2
Vasculitis (Vasculitides)
02/2014 - 10/2013
2
Cicatrix (Scar)
02/2014 - 09/2007
1
Vision Disorders (Hemeralopia)
04/2024
1
Neoplasms (Cancer)
10/2022
1
Infections
05/2022
1
Anterior Uveitis
05/2022
1
Sarcoidosis (Schaumann Disease)
05/2022
1
Macular Edema
01/2022
1
Foreign Bodies (Foreign Body)
05/2019
1
Cardiovascular Infections
03/2017
1
Bone Diseases (Bone Disease)
03/2017
1
Panuveitis
11/2016
1
Posterior Uveitis
02/2014
1
Scleritis (Episcleritis)
07/2013
1
Autoimmune Diseases (Autoimmune Disease)
07/2013
1
Systemic Vasculitis
07/2013
1
Choroidal Neovascularization
11/2010
1
Amblyopia (Lazy Eye)
09/2007
Drug/Important Bio-Agent (IBA)
3
Adrenal Cortex Hormones (Corticosteroids)
IBA
04/2024 - 11/2016
2
Fluocinolone Acetonide (Capex)
FDA Link
Generic
09/2023 - 04/2023
2
Steroids
IBA
01/2022 - 07/2013
2
dupilumab
IBA
05/2019 - 09/2018
2
Cytokines
IBA
10/2013 - 07/2013
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
10/2013 - 07/2013
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
10/2022
1
Immune Checkpoint Inhibitors
IBA
10/2022
1
HLA-B27 Antigen (HLA B27 Antigen)
IBA
05/2022
1
Dihydroorotate Dehydrogenase
IBA
01/2022
1
Enzymes
IBA
01/2022
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2022
1
Pyrimidines
IBA
01/2022
1
Monoclonal Antibodies
IBA
05/2019
1
Immunosuppressive Agents (Immunosuppressants)
IBA
03/2017
1
Sirolimus (Rapamycin)
FDA Link
11/2016
1
Green Or
IBA
02/2014
1
Retinaldehyde (Retinal)
IBA
02/2014
1
Antigen-Antibody Complex (Immune Complex)
IBA
10/2013
1
Autoantibodies
IBA
10/2013
1
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
07/2013
1
Antibodies
IBA
07/2013
1
Bevacizumab (Avastin)
FDA Link
11/2010
Therapy/Procedure
7
Therapeutics
04/2023 - 07/2013
1
Remission Induction
04/2023
1
Intraocular Injections
01/2022
1
Biological Therapy
03/2017
1
Cell- and Tissue-Based Therapy (Cell Therapy)
07/2013
1
Keratectomy
09/2007